|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Gilead Sciences, Inc.
| | | Phone: | (206) 728-5090 | Fax: | (206) 728-5095 | Year Established: | 1987 | Ticker: | GILD | Exchange: | NASDAQ | Main Contact: | Martin B. Silverstein, MD, Executive VP, Strategy | | Other Contacts: | Brett Pletcher, Executive VP & General Counsel John McHutchison, MD, Executive VP, Clinical Research Jim Meyers, Executive VP, Worldwide Commercial Operations Taiyin Yang, Ph.D., Senior VP, Pharmaceutical Development and Manufacturing Robin L. Washington, Executive VP & CFO Andrew Cheng, MD, Ph.D., Executive VP, Clinical Research and Development Operations Norbert W. Bischofberger, Ph.D., Executive VP, R&D & CSO Kevin Young, COO Gregg H. Alton, Executive VP, Commercial and Access Operations ALA, John F. Milligan, Ph.D., President & CEO John C. Martin, Ph.D., Executive Chairman
| | Company Description | Gilead Sciences (formerly Corus Pharma) is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. | |
|
|
|
|
|